A carregar...
Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer
Advances in target therapies for lung cancer have enabled detection of gene mutations, specifically those of EGFR. Assays largely depend on the acquisition of tumor tissue biopsy, which is invasive and may not reflect the genomic profile of the tumor at treatment due to tumor heterogeneity or change...
Na minha lista:
| Publicado no: | Expert Rev Mol Diagn |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4889428/ https://ncbi.nlm.nih.gov/pubmed/26420338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737159.2015.1094379 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|